Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (371-380 of 394) with videos related to

Pageof 40
Sort By:
Gastroenterology|November 9, 2024
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in CirrhosisNaoto Fujiwara, Camden Lopez, Tracey L Marsh, et al.
JCO Global Oncology|March 31, 2026
Lower Allele Frequency of <i>TERT</i>-rs2242652 in Sub-Saharan African Populations Compared With American Populations and Hepatocellular Carcinoma RiskPerapa Chotiprasidhi, Viviana P Gonzalez Umpierre, Yvonne Ayerki Nartey, et al.
Hepatology Communications|November 16, 2021
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> GaScott M Thompson, Garima Suman, Michael S Torbenson, et al.
Molecular Therapy. Oncology|January 6, 2025
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockadeMulu Z Tesfay, Yuguo Zhang, Khandoker U Ferdous, et al.
Gastroenterology|September 15, 2022
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular CarcinomaPhilipp K Haber, Florian Castet, Miguel Torres-Martin, et al.
Hepatology (Baltimore, Md.)|August 18, 2021
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancersMansi Arora, James M Bogenberger, Amro M Abdelrahman, et al.
Hepatology Communications|January 13, 2021
Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular CarcinomaVincent L Chen, Ming-Lun Yeh, Ju Dong Yang, et al.
International Journal of Cancer|October 23, 2025
Circulating cell-free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV-positive Nigerian populationYinan Zheng, Jingzhe Han, Yishu Qu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2018
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS ScoreJu Dong Yang, Benyam D Addissie, Kristin C Mara, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Pageof 40

Showing results (371-380 of 394) with videos related to

Sort By:
Pageof 40
Gastroenterology|November 9, 2024
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in CirrhosisNaoto Fujiwara, Camden Lopez, Tracey L Marsh, et al.
JCO Global Oncology|March 31, 2026
Lower Allele Frequency of <i>TERT</i>-rs2242652 in Sub-Saharan African Populations Compared With American Populations and Hepatocellular Carcinoma RiskPerapa Chotiprasidhi, Viviana P Gonzalez Umpierre, Yvonne Ayerki Nartey, et al.
Hepatology Communications|November 16, 2021
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> GaScott M Thompson, Garima Suman, Michael S Torbenson, et al.
Molecular Therapy. Oncology|January 6, 2025
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockadeMulu Z Tesfay, Yuguo Zhang, Khandoker U Ferdous, et al.
Gastroenterology|September 15, 2022
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular CarcinomaPhilipp K Haber, Florian Castet, Miguel Torres-Martin, et al.
Hepatology (Baltimore, Md.)|August 18, 2021
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancersMansi Arora, James M Bogenberger, Amro M Abdelrahman, et al.
Hepatology Communications|January 13, 2021
Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular CarcinomaVincent L Chen, Ming-Lun Yeh, Ju Dong Yang, et al.
International Journal of Cancer|October 23, 2025
Circulating cell-free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV-positive Nigerian populationYinan Zheng, Jingzhe Han, Yishu Qu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2018
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS ScoreJu Dong Yang, Benyam D Addissie, Kristin C Mara, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Pageof 40